Llanymynech, United Kingdom Dec 19, 2024 (Issuewire.com) - M2M Capital Invests in GenpharmaChain to Drive AI and Web3-Powered Drug Development
GenPharmaChain, a pioneering AI-driven biotech Web3 platform, has secured a strategic investment from M2M Capital. The funding will accelerate GenPharmaChains mission to harness AI and blockchain technologies for transformative advancements in drug discovery and development.
With a robust database comprising over 200 million protein sequences and extensive disease-related data, GenPharmaChain seeks to revolutionize the pharmaceutical industry. By integrating decentralized platforms, the company aims to enable faster, more secure, and transparent drug development processes.
About M2M Capital
M2M Capital is a leading venture capital firm specializing in investments across cutting-edge sectors, including blockchain, AI, and Web3 technologies. The firms portfolio includes notable innovators such as Panda Titan and Nexgendex, underscoring its commitment to driving groundbreaking advancements in technology.
Media Contact
More On Newsinterestcorp ::
- Stratton Reichen, MD, ACHE, ACP: Hospitalist, Hospice Leader, and Emerging Healthcare Visionary
- Local Dentist Jill M. Burns, DDS Enhances Smiles and Community Health in Richmond, Indiana
- Eddy Andrews Group: Bridging Innovation and Trust Across Diverse Professional Services
- Wings - Whispers: Tales of Friendship Vol 1 Finalist 2025 Children's Book International Competition
- Carina Hernandez, MD, PhD: From Chemistry to Medicine – A Journey of Excellence
genpharmachain
Source :Genpharmachain and M2M Capital
This article was originally published by IssueWire. Read the original article here.